We are live on
!
Find out more
Insmed
INSM
INSM
238 hedge funds and large institutions have $2.78B invested in Insmed in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 93 increasing their positions, 60 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 20
55% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 60
37% more call options, than puts
Call options by funds: $6.73M | Put options by funds: $4.93M
11% more funds holding
Funds holding: 214 → 238 (+24)
10% more capital invested
Capital invested by funds: $2.54B → $2.78B (+$247M)
0.76% more ownership
Funds ownership: 108.1% → 108.86% (+0.76%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
238
Holders Change
+24
Holders Change %
+11.21%
% of All Funds
4.1%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
45
Increased
93
Reduced
60
Closed
20
Calls
$6.73M
Puts
$4.93M
Net Calls
+$1.8M
Net Calls Change
+$1.47M
Top Buyers
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$18.2M |
| 2 |
Millennium Management
New York
|
+$16.3M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$12M |
| 4 |
Bank of New York Mellon
New York
|
+$10.6M |
| 5 |
Goldman Sachs
New York
|
+$9.65M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$160M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$51.2M |
| 3 |
Holocene Advisors
New York
|
-$27.9M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$25.4M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$20.3M |
